antifungals
aspergillosis
biomarker
mucormycosis
nuclear imaging
tracer
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
23 06 2020
23 06 2020
Historique:
received:
26
11
2019
accepted:
02
05
2020
pubmed:
13
5
2020
medline:
22
6
2021
entrez:
13
5
2020
Statut:
epublish
Résumé
Invasive pulmonary aspergillosis and mucormycosis are life-threatening complications in immunocompromised patients. A rapid diagnosis followed by early antifungal treatment is essential for patient survival. Given the limited spectrum of biomarkers for invasive mold infections, recent studies have proposed the use of radiolabeled siderophores or antibodies as molecular probes to increase the specificity of radiological findings by nuclear imaging modalities. While holding enormous diagnostic potential, most of the currently available molecular probes are tailored to the detection of
Identifiants
pubmed: 32393491
pii: AAC.02377-19
doi: 10.1128/AAC.02377-19
pmc: PMC7318046
pii:
doi:
Substances chimiques
Antifungal Agents
0
Amphotericin B
7XU7A7DROE
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 American Society for Microbiology.
Références
J Infect Dis. 2007 Feb 1;195(3):455-66
pubmed: 17205486
Curr Neurovasc Res. 2018;15(1):55-62
pubmed: 29557745
Drugs. 2013 Jun;73(9):919-34
pubmed: 23729001
Front Microbiol. 2019 Jan 08;9:3204
pubmed: 30671036
Curr Radiopharm. 2014;7(2):144-50
pubmed: 25314957
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1661-7
pubmed: 24903095
J Clin Microbiol. 2006 Dec;44(12):4342-4
pubmed: 17021057
Ann Nucl Med. 2014 Jul;28(6):523-30
pubmed: 24682926
J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i19-i28
pubmed: 28355464
Int J Med Microbiol. 2018 Dec;308(8):1009-1017
pubmed: 30197238
PLoS Pathog. 2015 Jan 29;11(1):e1004568
pubmed: 25634225
Antimicrob Agents Chemother. 2001 Feb;45(2):605-7
pubmed: 11158763
J Comput Assist Tomogr. 2013 Jul-Aug;37(4):596-601
pubmed: 23863538
Clin Infect Dis. 2005 Jun 15;40(12):1762-9
pubmed: 15909264
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E1026-33
pubmed: 26787852
Nucl Med Biol. 2004 May;31(4):511-22
pubmed: 15093822
Med Mycol. 2010 Feb;48(1):48-55
pubmed: 20055743
Antimicrob Agents Chemother. 2007 Jul;51(7):2587-90
pubmed: 17452481
AJR Am J Roentgenol. 2014 Jul;203(1):180-9
pubmed: 24951213
Clin Infect Dis. 2008 Aug 15;47(4):503-9
pubmed: 18611163
Mycoses. 2016 Apr;59(4):198-219
pubmed: 26810669
Curr Opin Pulm Med. 2015 May;21(3):260-71
pubmed: 25784246
Antimicrob Agents Chemother. 2008 Apr;52(4):1553-5
pubmed: 18268082
Emerg Infect Dis. 2009 Sep;15(9):1395-401
pubmed: 19788806
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38
pubmed: 29544767
Mayo Clin Proc. 2011 Aug;86(8):805-17
pubmed: 21803962
Theranostics. 2017 Aug 11;7(14):3398-3414
pubmed: 28912884
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60
pubmed: 27365388
Curr Opin Pulm Med. 2013 May;19(3):216-28
pubmed: 23524477
Med Mycol. 2018 Apr 1;56(suppl_1):73-82
pubmed: 29538736
Clin Respir J. 2018 Feb;12(2):499-509
pubmed: 27614086
Nucl Med Commun. 2002 Feb;23(2):121-30
pubmed: 11891465
Mol Imaging Biol. 2014 Feb;16(1):102-8
pubmed: 23818006
Clin Infect Dis. 2012 Feb;54 Suppl 1:S35-43
pubmed: 22247443
J Clin Microbiol. 2004 Sep;42(9):4154-7
pubmed: 15365004
PLoS One. 2014 May 28;9(5):e98279
pubmed: 24870357
Clin Infect Dis. 2005 Sep 1;41(5):634-53
pubmed: 16080086
Mycoses. 2002 Jun;45(5-6):166-9
pubmed: 12100533
Recent Results Cancer Res. 2013;194:189-219
pubmed: 22918761
Antimicrob Agents Chemother. 2002 May;46(5):1583-5
pubmed: 11959606
Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S81-7
pubmed: 20597676
Curr Drug Targets. 2005 Dec;6(8):945-54
pubmed: 16375677
Drugs. 2016 Mar;76(4):485-500
pubmed: 26818726
Front Microbiol. 2018 Apr 09;9:691
pubmed: 29686661